Serological Response After the Fourth Dose of COVID-19 Vaccine in Highly Immunosuppressed Patients
Most immunosuppressed patients achieved seroconversion after the fourth dose. These results underscore the need for tailored vaccination strategies and additional measures in highly immunosuppressed subgroups.
Authors
- Daniel Carmona (ORCID: https://orcid.org/0000-0003-4196-5856)
- Abelardo Claudio Fernández Chávez (ORCID: https://orcid.org/0000-0002-7259-7649)
- P Lopez (ORCID: https://orcid.org/0009-0006-4835-5275)
- Ana Martín (ORCID: https://orcid.org/0000-0002-7822-0156)
- Jesús María Aranaz Andrés
- Guillermo Yovany Ordoñez León (ORCID: https://orcid.org/0009-0002-6779-0791)
Institutions
- Universidad de Valladolid (ES)
- Instituto Cajal (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Universidad Internacional De La Rioja (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Hospital Clínico Universitario de Valladolid (ES)
- Hospital Universitario Ramón y Cajal (ES)
Publication Details
- Journal
- Vaccines
- Published
- 2025-09-23
- DOI
- https://doi.org/10.3390/vaccines13100994
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00